TDOC logo

TELADOC HEALTH INC

TDOCNYSE
πŸ† #2414 by market capUS Equity
$543.28β–² $37.65 (+6.93%)
Simulated price
πŸ””
Track TDOC
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 6.9%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$1.11B
Small Cap
πŸ“ˆRevenue Growth (YoY)
-1.5%
Declining
πŸ“ŠGross Margin
73.5%
High
πŸ’΅FCF Margin
9.0%
Moderate
βš–οΈP/S Ratio
0.4x
Cheap
Otter Score
68
Fair
No chart data available for TDOC.

Trading Snapshot

Day Range
$538.48 – $547.64
52-Week Range
$4.40 – $9.89
Volume
$2.00B
Avg Volume
$2.54B
Shares Outstanding
181.7M
Next Earnings
Nov 7, 2026

Fundamentals Snapshot

Annual Revenue
$2.53B
Last Q Revenue
$607M
P/E Ratio
-6.2
P/S Ratio
0.4x
EPS (TTM)
$-0.99
Dividend Yield
0.00%
Dilution (1yr)
+2.0%

Why Investors Own TDOC

  • βœ“High-growth profile β€” revenue up -0.9% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 60% gross margin and 14% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

TDOC logo

TELADOC HEALTH INC

TDOC
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$2.5Bβ–Ό βˆ’1.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
69.5%β–Ό βˆ’1.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$263Mβ–Ό βˆ’74.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$285Mβ–² +0.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
176.2Mβ–² +2.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$259Mβ–² +$27M YoY
StockOtter Β· stockotter.space

About TELADOC HEALTH INC

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
68/100

Analyst Price Target

β“˜
Average Target
$668.88
β–² +23.1% Upside
High Target$803.40
Low Target$502.29
Based on 34 analysts

Latest News & Updates